Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Published: 01 September 2020

Views:
56
Likes:
7

Views:
56
Likes:
7
Share:

Now Playing
Part 1
Welcome
Kurt Huber

Up Next

15m 14s

Part 2 Pre-treatment in NSTE-ACS – Dead or Alive?
Davide Capodanno

18m 1s

Part 3 Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials
Stefan James

12m 18s

Part 4 When to leave Aspirin behind?
Roxana Mehran

13m 38s

Part 5 Q&As
Kurt Huber, Davide Capodanno, Stefan James, Roxana Mehran

Average (ratings)

No ratings

Your rating

Overview

In this series of videos Kurt Huber, Davide Capodanno, Stefan James and Roxana Mehran discuss Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Supported by an unrestricted educational grant from AstraZeneca

Learning Objectives

Review the clinical landscape for antiplatelet therapy in patients with ACS.
Discuss recent data on DAPT for patients with ACS
Provide expert insight on application in routine clinical practice

More from this programme

Part 1

Welcome

1 session
Welcome	Watch now

Part 2

Pre-treatment in NSTE-ACS – Dead or Alive?

1 session
Pre-treatment in NSTE-ACS – Dead or Alive?	Watch now

Part 3

Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials

1 session
Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials	Watch now

Part 4

When to leave Aspirin behind?

1 session
When to leave Aspirin behind?	Watch now

Part 5

Q&As

1 session
Q&As	Watch now

Faculty Biographies

Kurt Huber

View full profile